2007 News Archive

December 20, 2007
ImpediMed Gets Positive Reimbursement Report
December 18, 2007
ImpediMed Investor Presentation Dec 2007
November 22, 2007
Leading Lymphedema Text Recognizes Bioimpedance Technology
November 12, 2007
ImpediMed Announces Lympedema Products US Distribution Launch
November 01, 2007
ImpediMed CEO Greg Brown on Board Room Radio re Xitron Technologi ...
November 01, 2007
Becoming a Substantial Holder - Thorpe Road Nominees
October 26, 2007
Becoming a Substantial Holder
October 26, 2007
Becoming a Substantial Holder 2
October 26, 2007
Change of Director's Interest Notice - Mel Bridges
October 24, 2007
Becoming a Substantial Holder x2
October 24, 2007
Becoming a Substantial Holder from MBL
October 23, 2007
IPD Amended Distribution Schedule and Top 20 for Option Exp
October 23, 2007
IPD Amended Distribution Schedules and top 20 lists
October 22, 2007
ImpediMed Admitted to ASX Official List Today 22nd October 2007
October 18, 2007
ImpediMed Distribution Schedule
October 18, 2007
Corporate Governance Principles Compliance
October 18, 2007
Statement re Commitments Based on Funds Raised
October 16, 2007
Constitution of ImpediMed Ltd
October 09, 2007
Undertaking to Restrict Securities
October 01, 2007
ASX Circular: Commencement of Official Quotation
October 01, 2007
Appendix 1A: ASX Listing Application and Agreement
October 01, 2007
ImpediMed Top 20 Share and Option holders
October 01, 2007
ImpediMed Updated Pro Forma Balance Sheet
October 01, 2007
ImpediMed Option Plan
October 01, 2007
IPD Restricted Securities
October 01, 2007
Performance Share Plan
October 01, 2007
Circulating Resolution Issue of Shares to Xitron Vendors
October 01, 2007
IPD Allotment Confirmations
October 01, 2007
IPD IPO Option Terms
October 01, 2007
Notice of Initial Substantial Holder - Parma Corporation
October 01, 2007
Notice of Initial Substantial Holder - Mel Bridges
October 01, 2007
Notice of Initial Substantial Holder - Greg Brown
October 01, 2007
Notice of Initial Substantial Holder - ImpediMed Limited
October 01, 2007
Initial Director's Interest Notice - Mel Bridges
October 01, 2007
Initial Director's Interest Notice - Greg Brown
October 01, 2007
ImpediMed Completes US Acquisition of XITRON Technologies
October 01, 2007
Initial Director's Interest Notice - Martin Kriewaldt
October 01, 2007
Initial Director's Interest Notice - Dr Cherrell Hirst
October 01, 2007
Initial Director's Interest Notice - Dr Michael Panacco
October 01, 2007
Initial Director's Interest Notice - James Hazel
September 25, 2007
ImpediMed Capital Raising Targets US$4.4 Billion Global Cancer Me ...
September 01, 2007
New Technology Gives Hope to Cancer Survivors
May 01, 2007
ImpediVET™ Launched at Experimental Biology for Lab Animal Rese ...
May 01, 2007
ImpediMed Featured in NIH Lymphedema Study